Advertisement

Traversing the genomic landscape of prostate cancer from diagnosis to death.

20:58 EDT 25th May 2013 | BioPortfolio

Summary of "Traversing the genomic landscape of prostate cancer from diagnosis to death."

The clinical spectrum of prostate cancer ranges from curable, local disease to widely metastatic, lethal cancer. Two new prostate cancer genome studies provide the first glimpse at both ends of this spectrum.

Affiliation

Human Oncology and Pathogenesis Program at the Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

Journal Details

This article was published in the following journal.

Name: Nature genetics
ISSN: 1546-1718
Pages: 613-4

Links

Medical and Biotech [MESH] Definitions

Prostate-specific Antigen

A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.

Fenretinide

A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.

Ultrasound, High-intensity Focused, Transrectal

Tissue ablation of the PROSTATE performed by ultrasound from a transducer placed in the RECTUM. The procedure is used to treat prostate cancer (PROSTATIC NEOPLASMS) and benign prostatic hypertrophy (PROSTATIC HYPERPLASIA).

Prostatic Secretory Proteins

Proteins secreted by the prostate gland. The major secretory proteins from the human prostate gland include PROSTATE-SPECIFIC ANTIGEN, prostate-specific acid phosphatase, prostate-specific membrane antigen, and prostate-specific protein-94.

Prostatic Neoplasms

Tumors or cancer of the PROSTATE.

PubMed Articles [ 30756 Associated PubMed Articles listed on BioPortfolio]

Risk of prostate cancer death in long-term users of warfarin: a population-based case-control study.

PURPOSE: Recent evidence suggests that warfarin use may be associated with a reduced risk of prostate cancer. We aimed to determine whether exposure to warfarin is also associated with a reduced risk...

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

OBJECTIVE: To determine the relation between concentrations of prostate specific antigen at age 60 and subsequent diagnosis of clinically relevant prostate cancer in an unscreened population to evalua...

Prostate cancer: Painting the genetic landscape of prostate cancer.

The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing.

Prostate cancer is a leading cause of global cancer-related death but attempts to improve diagnoses and develop novel therapies have been confounded by significant patient heterogeneity. In recent yea...

To screen or not to screen: ongoing debate in the early detection of prostate cancer.

Debate about the use of prostate-specific antigen (PSA) tests to screen prostate cancer in men is ongoing. Prostate cancer is the most common cancer after skin cancer in men and the second most deadly...

Clinical Trials [ 4417 Associated Clinical Trials listed on BioPortfolio]

Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly

The widespread availability of screening coupled with high risks of over diagnosis, over treatment, and a rising risk of dying from competing causes of deaths pose a major challenge for pr...

Transcranial Doppler Ultrasonography and Brain Death

In France the diagnosis of brain death relies on electroencephalography (EEG) or cerebral angiography. Concerning the latter a time of 6 hours is mandatory between the clinical diagnosis a...

Imaging of Prostate Cancer Using Two-Dimensional MR Spectroscopy and Diffusion Tensor Imaging

The goal is to develop MR imaging techniques to improve delineation of cancer extent, and to improve differential diagnosis between prostate cancer and benign prostate hyperplasia or other...

Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions

To develop the hypothesis that quantitative NMR spectroscopy of human semen can be used to diagnose prostate cancer.

Vitamin D Supplementation in Veterans With Early-Stage Prostate Cancer

Vitamin D promotes the differentiation of prostate cancer cells, maintains the differentiated phenotype of prostate epithelial cells, and can induce prostate cancer cell death, raising the...

Search BioPortfolio: